Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carfilzomib”

225 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 225 results

Testing effectiveness (Phase 2)Study completedNCT02405364
What this trial is testing

Front-line Therapy With Carfilzomib, Lenalidomide, and Dexamethasone Induction

Who this might be right for
Multiple Myeloma
University Hospital, Toulouse 46
Not applicableNot Yet RecruitingNCT07015021
What this trial is testing

The Efficacy and Safety of the Combination Therapy of Daratumumab, Cabozantinib, Pomalidomide, and Dexamethasone (D-KPd) in the Treatment of High-risk First-time Relapsed or Primary Refractory MM Patients

Who this might be right for
Multiple MyelomaCarfilzomibDaratumumab+1 more
The First Affiliated Hospital of Soochow University 72
Testing effectiveness (Phase 2)Study completedNCT02937571
What this trial is testing

High Dose Carfilzomib for Newly Diagnosed Myeloma

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 29
Early research (Phase 1)Study completedNCT02142530
What this trial is testing

Carfilzomib Plus Belinostat in Relapsed/Refractory NHL

Who this might be right for
Non-Hodgkin LymphomaDiffuse Large B-cell LymphomaMantle Cell Lymphoma+2 more
Massachusetts General Hospital 19
Testing effectiveness (Phase 2)Study completedNCT00530816
What this trial is testing

Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Amgen 164
Post-approval studies (Phase 4)Study completedNCT03934684
What this trial is testing

Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed Refractory Multiple Myeloma
Amgen 101
Testing effectiveness (Phase 2)Ended earlyNCT01969565
What this trial is testing

Study of Carfilzomib in Combination w/Dexamethasone in Patients w/Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Emory University 1
Not applicableStudy completedNCT03375567
What this trial is testing

Global Response Assessment by Advanced Imaging and Myeloma Lesion Biopsies During Induction Therapy of Multiple Myeloma With Carfilzomib Lenalidomide Dexamethasone

Who this might be right for
Multiple Myeloma
Yale University 28
Early research (Phase 1)Study completedNCT02199665
What this trial is testing

Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Refractory Multiple Myeloma
University of Chicago 52
Testing effectiveness (Phase 2)Study completedNCT03773107
What this trial is testing

LCI-HEM-MYE-CRD-004 (MMRC-073 CARJAK): Study of CRD for Carfilzomib-Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Wake Forest University Health Sciences 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04113018
What this trial is testing

Study of Daratumumab Combined With Carfilzomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Wake Forest University Health Sciences 39
Large-scale testing (Phase 3)Looking for participantsNCT06561854
What this trial is testing

Study Comparing Therapy for Advanced Relapsed/Refractory Multiple Myeloma With and Without Dexamethasone

Who this might be right for
Multiple MyelomaRelapse Multiple Myeloma
Assistance Publique - Hôpitaux de Paris 318
Testing effectiveness (Phase 2)Ended earlyNCT02128230
What this trial is testing

UARK 2012-02 Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete Remission

Who this might be right for
Multiple Myeloma
University of Arkansas 20
Early research (Phase 1)Study completedNCT02811822
What this trial is testing

Determine the Efficacy, Safety and Pharmacokinetics of GMI-1271 as Adjunct to Standard of Care for the Treatment of Multiple Myeloma

Who this might be right for
Multiple Myeloma
GlycoMimetics Incorporated 10
Testing effectiveness (Phase 2)Study completedNCT02891811
What this trial is testing

Patients With Newly Diagnosed Multiple Myeloma Comparing KTd vs. KRd Induction Therapy and Investigating a K-mono Maintenance Strategy

Who this might be right for
Multiple Myeloma
Arbeitsgemeinschaft medikamentoese Tumortherapie 124
Early research (Phase 1)Study completedNCT01137747
What this trial is testing

Carfilzomib in Patients With Relapsed Acute Myeloid or Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Washington University School of Medicine 18
Not applicableUnknownNCT05041933
What this trial is testing

Secure Outsourcing of Carfilzomib in the Treatment of Multiple Myeloma to the Hospital at Home Setting

Who this might be right for
Hematological Diseases
University Hospital, Limoges 20
Testing effectiveness (Phase 2)Study completedNCT01346787
What this trial is testing

Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
European Myeloma Network B.V. 58
Testing effectiveness (Phase 2)Study completedNCT01813227
What this trial is testing

A Phase II Study of Carfilzomib in Relapsed Waldenström's Macroglobulinemia (WM) IST-CAR-531

Who this might be right for
Waldenstrom Macroglobulinemia
Hackensack Meridian Health 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT04764942
What this trial is testing

Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With Relapsed Refractory Multiple Myeloma, The SCOPE Trial

Who this might be right for
Recurrent Multiple MyelomaRefractory Multiple Myeloma
Mayo Clinic 39
Load More Results